<DOC>
	<DOCNO>NCT02959983</DOCNO>
	<brief_summary>This study evaluate efficacy safety eluxadoline 100 milligram ( mg ) twice day ( BID ) versus placebo treatment patient Irritable Bowel Syndrome Diarrhea ( IBS-D ) report use loperamide prior 12 month fail provide control IBS-D symptom .</brief_summary>
	<brief_title>Efficacy Eluxadoline Treatment Irritable Bowel Syndrome With Diarrhea Patients With Inadequate Control Symptoms With Prior Loperamide Use</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<mesh_term>Eluxadoline</mesh_term>
	<criteria>Has diagnosis IBSD , define Rome III criterion loose ( mushy ) watery stools ≥25 % hard lumpy stool ≤25 % bowel movement . Has colonoscopy perform within 5 year prior Screening least 50 year age , OR meet follow alarm feature : 1 . Has document weight loss within past 6 month ; 2 . Has nocturnal symptom ; 3 . Has familial history colon cancer ; 4 . Has blood mixed stool ( exclude blood hemorrhoid ) Patient report use loperamide 12 month prior Screening IBSD symptom loperamide provide adequate control IBSD symptom . Has use loperamide rescue medication within 14 day prior randomization . Has diagnosis Irritable Bowel Syndrome ( IBS ) subtype constipation IBS , mixed IBS , unsubtyped IBS . Has history inflammatory immunemediated gastrointestinal ( GI ) disorder include inflammatory bowel disease ( i.e. , Crohn 's disease , ulcerative colitis ) , microscopic colitis , celiac disease . Has history diverticulitis within 3 month prior screen . Has document history lactose intolerance . Has document history bileacid malabsorption . Has history chronic severe constipation intestinal obstruction , stricture , toxic megacolon , GI perforation , fecal impaction , gastric banding , bariatric surgery , adhesion . Has follow surgical history : 1 . Cholecystectomy previously document agenesis gallbladder ; 2 . Any abdominal surgery within 3 month prior screen ; 3 . Major gastric , hepatic , pancreatic , intestinal surgery ( appendectomy , hemorrhoidectomy , polypectomy great 3 month postsurgery allow ) . Has history cholecystitis within 6 month screen . Has history pancreatitis structural disease pancreas , include know suspected pancreatic duct obstruction . Has history know suspected biliary duct obstruction sphincter Oddi disease dysfunction , exclude history gallstone . Has history current evidence laxative abuse within 5 year prior screen . Has document evidence cirrhosis . Has history cardiovascular event , include stroke , myocardial infarction , congestive heart failure , transient ischemic attack within 6 month prior screen . Has unstable renal , hepatic , metabolic , hematologic condition . Has history malignancy within 5 year screen ( except squamous basal cell carcinomas cervical carcinoma situ ) . Has history human immunodeficiency virus infection . Has history Diagnostic Statistical Manual Mental Disorders , 4th Edition , Text Revisiondefined substance dependency , exclude nicotine caffeine , within 2 year prior screen . Has history alcohol abuse , alcohol addiction , alcoholism drink 3 alcoholic beverage per day . Has use aspirin aspirincontaining medication ( &gt; 325 mg aspirin per day ) nonsteroidal antiinflammatory drug , take specifically symptoms IBS , within 14 day randomization . Has current ( within 14 day randomization ) expect use narcotic opioidcontaining agent , tramadol , docusate , enema , GI preparation ( include antacid contain aluminum magnesium , antidiarrheal agent [ except loperamide rescue medication randomization ] ) , antinausea agent , antispasmodic agent , bismuth , prokinetic agent . Has current ( within 28 day randomization ) use rifaximin antibiotic ( exception topical antibiotic 1day course antibiotic ) . Expected use rifaximin antibiotic course study know time randomization . Has elective surgery plan expect need elective surgery time study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>